» Articles » PMID: 37415610

Dihydroartemisinin Ameliorates Cerebral I/R Injury in Rats Via Regulating VWF and Autophagy-mediated SIRT1/FOXO1 Pathway

Overview
Journal Open Med (Wars)
Specialty General Medicine
Date 2023 Jul 7
PMID 37415610
Authors
Affiliations
Soon will be listed here.
Abstract

Dihydroartemisinin (DHA) has been found to inhibit the expression of von Willebrand factor (VWF), a marker of endothelial cell injury, but its mechanism in cerebral ischemia/reperfusion (I/R) injury remains obscure. In this study, I/R model was constructed through middle cerebral artery occlusion (MCAO) in rats, followed by DHA administration. The effect of DHA on rat cerebral I/R injury was investigated by 2,3,5-triphenyltetrazolium chloride staining, hematoxylin and eosin staining, TUNEL staining, and Western blot. Brain microvascular endothelial cells (BMVECs) isolated from newborn rats were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R), and then treated with DHA. The results showed that MCAO treatment induced infarction, nerve cell apoptosis, and brain tissue impairment in rats, which was mitigated by DHA. OGD/R inhibited viability and accelerated apoptosis of BMVECs, which was alleviated by DHA. I/R procedures or OGD/R up-regulated expressions of VWF, ATG7, Beclin1, and LC3-II/LC3-I ratio, while down-regulating Occludin, Claudin-5, ZO-1, P62, SIRT1, and FOXO1 expressions and ; however, these effects of I/R procedures or OGD/R were offset by DHA. VWF overexpression reversed the above effects of DHA on OGD/R-induced BMVECs. In summary, DHA ameliorates cerebral I/R injury in rats by reducing VWF level and activating autophagy-mediated SIRT1/FOXO1 signaling pathway.

Citing Articles

Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy.

Gao Y, Li L, Zhao F, Cheng Y, Jin M, Xue F Drug Des Devel Ther. 2025; 19:369-387.

PMID: 39867864 PMC: 11760763. DOI: 10.2147/DDDT.S504179.


Protective Role of Oxycodone in Myocardial Oxidative Stress and Mitochondrial Dysfunction Induced by Ischemia-Reperfusion.

Jiang Y, He H, Jia X J Biochem Mol Toxicol. 2025; 39(2):e70151.

PMID: 39865943 PMC: 11837462. DOI: 10.1002/jbt.70151.


From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1.

Law M, Wang P, Zhou Z, Wang Y Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598406 PMC: 11597311. DOI: 10.3390/ph17111495.

References
1.
Shi C, Jin J, Wang X, Song T, Li G, Li K . Sevoflurane attenuates brain damage through inhibiting autophagy and apoptosis in cerebral ischemia‑reperfusion rats. Mol Med Rep. 2019; 21(1):123-130. PMC: 6896401. DOI: 10.3892/mmr.2019.10832. View

2.
Haybar H, Khodadi E, Kavianpour M, Saki N . Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis. Cardiovasc Hematol Disord Drug Targets. 2018; 18(3):176-181. DOI: 10.2174/1871529X18666180419102214. View

3.
Ilett K, Ethell B, Maggs J, Davis T, Batty K, Burchell B . Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos. 2002; 30(9):1005-12. DOI: 10.1124/dmd.30.9.1005. View

4.
Wu Q, Hu Y, Jiang M, Wang F, Gong G . Effect of Autophagy Regulated by Sirt1/FoxO1 Pathway on the Release of Factors Promoting Thrombosis from Vascular Endothelial Cells. Int J Mol Sci. 2019; 20(17). PMC: 6747322. DOI: 10.3390/ijms20174132. View

5.
Mizushima N, Yoshimori T, Levine B . Methods in mammalian autophagy research. Cell. 2010; 140(3):313-26. PMC: 2852113. DOI: 10.1016/j.cell.2010.01.028. View